[HTML][HTML] A comparison of traditional and novel methods for the separation of exosomes from human samples

…, J Zhu, JX Liu, F Jiang, WK Ni, LS Qu, RZ Ni… - BioMed research …, 2018 - hindawi.com
Exosomes are discrete populations of small (40-200 nm in diameter) membranous vesicles
that are released into the extracellular space by most cell types, eventually accumulating in …

The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms

X Li, R Ni, J Chen, Z Liu, M Xiao, F Jiang, C Lu - Pancreas, 2011 - journals.lww.com
Objectives: To investigate the expression of Igγ-1 chain C region (IGHG1) in human
pancreatic carcinomas and determine the biological function of IGHG1 expression in immune …

Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma

…, L Yu, G Liu, K Chen, J Shi, Y Zhang, R Ni - Digestive diseases and …, 2013 - Springer
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths
worldwide. It is important to understand molecular mechanisms of HCC progression and to …

Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy

X Xie, H Wu, M Li, X Chen, X Xu, W Ni, C Lu, R Ni… - Cytotherapy, 2019 - Elsevier
Cancer is the second leading cause of death in the world with a high annual incidence level.
Researchers have been working on developing treatments for cancer. Targeted therapy is …

Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition

J Liu, C Lu, M Xiao, F Jiang, L Qu, R Ni - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Background Recently, Accumulating evidence indicates that long noncoding RNAs (lncRNAs)
have been shown to have critical regulatory roles in human tumor biology and …

[HTML][HTML] S100 family signaling network and related proteins in pancreatic cancer

…, HUA Huang, F Jiang, RZ Ni… - … journal of molecular …, 2014 - spandidos-publications.com
The occurrence and development of pancreatic cancer is a complex process convoluted by
multi-pathogenies, multi-stages and multi-factors. S100 proteins are members of the S100 …

[HTML][HTML] Identification and validation of the N6-methyladenosine RNA methylation regulator YTHDF1 as a novel prognostic marker and potential target for …

S Bian, W Ni, M Zhu, Q Song, J Zhang, R Ni… - Frontiers in molecular …, 2020 - frontiersin.org
Purpose: N6-methyladenosine (m 6 A) RNA methylation has been implicated in various
malignancies. This study aimed to identify the m 6 A methylation regulator-based prognostic …

Fas-mediated apoptosis in primary cultured mouse hepatocytes

R Ni, Y Tomita, K Matsuda, A Ichihara, K Ishimura… - Experimental cell …, 1994 - Elsevier
The Fas antigen is a member of the tumor necrosis factor/nerve growth factor receptor family
and is expressed in tissues such as the thymus, liver, and ovary. Agonistic anti-Fas …

Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell …

…, D Yang, X Cui, J Cai, L Lv, S He, Y Zhang, R Ni - Human Pathology, 2014 - Elsevier
Glycinamide ribonucleotide transformylase (GART) is a folate-dependent enzyme in the de
novo purine pathway that has been the target of antineoplastic intervention for almost 2 …

Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: Correlation with Skp2 …

Y Zhao, Q Tang, R Ni, X Huang, Y Wang, C Lu, A Shen… - Human pathology, 2013 - Elsevier
Early mitotic inhibitor-1 (Emi1) is a key cell-cycle regulator that promotes S-phase and M-phase
entry by inhibiting anaphase-promoting complex/cyclosome (APC/C) activity. …